Major Companies in India Restless Leg Syndrome Market | Insights & Key Players 2026

Major Companies in India Restless Leg Syndrome Market

India Restless Leg Syndrome market represents a rapidly expanding segment within the country's pharmaceutical and neurology sectors, playing a vital role in enhancing neurological health, improving patient quality of life, and advancing therapeutic care. Key players in the market are Sun Pharmaceutical Industries, Cipla, Lupin Limited, Intas Pharmaceuticals, and Dr. Reddy's Laboratories.

India Restless Leg Syndrome Market Overview

According to 6Wresearch, the India Restless Leg Syndrome market is witnessing steady growth due to increasing awareness of neurological disorders and the rising prevalence of sleep and movement disorders. This growth is driven by the expanding patient population, improved healthcare infrastructure, and government initiatives to promote mental health. The market also benefits from the increasing availability of prescription drugs in retail and hospital pharmacies and the increasing focus of pharmaceutical companies on patient-centric therapies.

Competitive Landscape

The competitive landscape of the India Restless Leg Syndrome market is a combination of global pharmaceutical giants and established Indian companies. These companies have a wide variety of products, such as branded drugs and generic formulations as well as innovative delivery systems that improve patient adherence and therapeutic outcomes.

Leading Players Operating in the India Restless Leg Syndrome Market:

1. Sun Pharmaceutical Industries Limited

A global leader in specialty generics, Sun Pharma provides sophisticated therapeutic solutions for neurological disorders, ensuring reliable management of RLS symptoms.

2. Cipla Limited

A major force in the global space, Cipla focuses on broad-spectrum compliance and standardized medication delivery for chronic conditions, including nocturnal sensory-motor disorders.

3. Lupin Limited

A fast-growing leader in the chronic segment that provides an end-to-end management suite for neurological patients, integrating quality hardware with therapeutic efficacy.

4. Intas Pharmaceuticals Limited

Caters to the modern clinical workforce with a physician-centric platform that emphasizes patient transparency in treatment processing and ease of care.

5. Dr. Reddy's Laboratories Limited

Combines neurological research excellence with software-driven manufacturing, offering high-precision active pharmaceutical ingredients for effective RLS symptom control.

6. Glenmark Pharmaceuticals Limited

A mobile-first platform that leverages deep clinical data to provide high-precision patient monitoring and system processing for various neurological disorders.

7. Aurobindo Pharma Limited

Part of the global health ecosystem, this brand focuses on providing affordable, highly customizable neuro-medication tools integrated with broad business applications.

8. Mankind Pharma Limited

Provides high-volume processing and management solutions, supporting some of the largest private neurology centers and sleep clinics in the country.

9. Emcure Pharmaceuticals Limited

Specializes in managed care and clinical efficacy audits, delivering reliable quaternary care for complex neurological operations and treatment frameworks.

10. Zydus Lifesciences Limited

Provides high-durability chemical processing and system management solutions, supporting some of the largest industrial and hospital frameworks in the country.

11. Ajanta Pharma Limited

Focuses on specialty delivery mechanisms, providing targeted formulations that enhance bioavailability for RLS patients needing nocturnal relief.

Major Companies in India Restless Leg Syndrome Market: FAQs